Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 14;12(1):4368.
doi: 10.1038/s41598-022-07855-4.

Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity

Ursula Pia Ferrara  1 , Cristina Tortora  2 , Carmen Rosano  1 , Antonia Assunto  1 , Alessandro Rossi  1 , Stefano Pagano  1 , Mariateresa Falco  3 , Chiara Simeoli  4 , Rosario Ferrigno  4 , Alessandra D'Amico  5 , Dario Di Salvio  1 , Giuliana Cangemi  6 , Rosario Pivonello  4 , Pietro Strisciuglio  1 , Daniela Melis  7   8   9
Affiliations

Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity

Ursula Pia Ferrara et al. Sci Rep. .

Abstract

Bone metabolism has been rarely investigated in children affected by Neurofibromatosis type 1 (NF1). Aim of the present study was to assess bone mineral metabolism in children and adults NF1 patients, to determine the relevant factors potentially involved in the development of reduced bone mineral density (BMD), and provide possible therapeutic intervention in NF1 patients. 114 NF1 patients and sex and age matched controls were enrolled into the study. Clinical and biochemical factors reflecting bone metabolism were evaluated. Factors potentially affecting BMD were also investigated including: physical activity, sun exposure, vitamin D intake. Whenever the presence of vitamin D deficiency was recorded, cholecalciferol supplementation was started and z-score data obtained at Dual-Energy X-ray Absorptiometry (DXA) during supplementation were compared with previous ones. NF1 patients showed lower Z-scores at Dual-Energy X-ray Absorptiometry DXA than controls. Physical activity was significantly reduced in NF1 patients than in controls. Sun exposure was significantly lower in NF1 compared to control subjects. At linear regression analysis vitamin D was the most predictive factor of reduced z-score at DXA (p = 0.0001). Cholecalciferol supplementation significantly increased BMD z-score (p < 0.001). We speculated that a combination of different factors, including reduced sun exposure, possibly associated with reduced serum vitamin D levels, and poor physical activity, concur to the impaired bone status in NF1 patients. We also demonstrated that treatment with vitamin D can be effective in improving z-score value in NF1 patients, including children. In conclusion, the findings of the current study are expected to have important implications for the follow-up and prevention of osteopenia/osteoporosis in this common genetic disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Correlation between vitamin D serum levels and bone mineral density values.
Figure 2
Figure 2
Bone mineral density data in patients at baseline (black) and after at least two years of cholecalciferol supplementation (grey).
See this image and copyright information in PMC

References

    1. Ferner R. Neurofibromatosis 1 and neurofibromatosis 2: A twenty-first century perspective. Lancet Neurol. 2007;6:340–351. - PubMed
    1. Stumpf D, Alksne J, Annegers J, Brown S, Conneally P, Housman D, et al. Neurofibromatosis. Arch. Neurol. 1988;45:575–578. - PubMed
    1. Assunto A, Ferrara U, De Luca A, Pivonello C, Lombardo L, Piscitelli A, et al. Isoform-specific NF1 mRNA levels correlate with disease severity in neurofibromatosis type 1. Orphanet. J. Rare Dis. 2019;15(14):261. - PMC - PubMed
    1. Kallionpää RA, Uusitalo E, Leppävirta J, Pöyhönen M, Peltonen S, Peltonen J. Prevalence of neurofibromatosis type 1 in the Finnish population. Genet. Med. 2018;20(9):1082–1086. - PubMed
    1. Pasmant E, Parfait B, Luscan A, et al. Neurofibromatosis type 1 molecular diagnosis: What can NGS do for you when you have a large gene with loss of function mutations? Eur. J. Hum. Genet. 2015;23:596–601. - PMC - PubMed